好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Perspectives on Clinical Research Participation Among Hispanic and NonHispanic Participants in an Online Research Study
Movement Disorders
P4 - Poster Session 4 (5:00 PM-6:00 PM)
5-022

To understand  attitudes and identify barriers to participation in clinical research in Hispanic people with PD (PwPD) and without PD (pwoPD).

Generalizability of research findings requires participation of all communities. Identifying participation barriers will help develop strategies to improve inclusivity, leading to more equitable health outcomes.

Participants in the online Fox Insight study were invited to complete a questionnaire assessing interest and barriers to participating in clinical research. Willingness to participate in research activities and barriers to participation were compared between participants identifying as Hispanic or nonHispanic using  Fisher’s exact test, controlling for PD diagnosis, gender and age.

Among the 6040 NonHispanic participants, 69.8% were PwPD (51.1% male, mean age 68.56), and 30.2% were PwoPD (22.9% male, mean age 62.78). Among the 245 Hispanic participants, 73.1% were PwPD (48.0 % male, mean age 64.45), and 26.9% were PwoPD (21.2% male, mean age 54.32).

Barriers to participating in research were reported by 70% of participants and were similar for Hispanics and nonHispanics. Hispanics were less likely to choose to participate in research than nonHispanics.  6% of nonHispanics and 9% of Hispanics indicated they would not choose to participate in any research activity. Research activities that fewer Hispanics would participate in included surveys (93.1% nonHispanics vs 87.3% Hispanics would participate), interviews (85.1% nonHispanics vs 76.3% Hispanics), biological samples (85.5% nonHispanics vs 78.4 % Hispanics), imaging studies (72.0% nonHispanic vs 62.4 % Hispanics), and exercise (74.4% nonHispanic vs 67.3% Hispanics).  Hispanic and nonHispanic participants were similarly willing to take medication or have brain surgery.

Hispanics report more hesitancy to participate in many clinical research activities despite reporting similar barriers to participation as nonHispanics report. Future efforts to understand the reasons for this hesitancy, and to develop ways to increase inclusion of Hispanics in  PD research  are needed.

Authors/Disclosures
Alberto Garcia Villasenor
PRESENTER
Mr. Garcia Villasenor has nothing to disclose.
Cheryl Meng, MPH Miss Meng has nothing to disclose.
Xuejie Chen, PhD Dr. Chen has nothing to disclose.
Ethan G. Brown, MD (University of California, San Francisco) Dr. Brown has received personal compensation in the range of $0-$499 for serving as a Consultant for Rune Labs, Inc. An immediate family member of Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Brown has received personal compensation in the range of $0-$499 for serving as a Consultant for Guidepoint Inc. An immediate family member of Dr. Brown has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Brown has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Knowledge Plus. Dr. Brown has stock in 153 Therapeutics. The institution of Dr. Brown has received research support from Michael J. Fox Foundation. The institution of Dr. Brown has received research support from NIH.
Monica Korell, MPH Ms. Korell has nothing to disclose.
Caroline M. Tanner, MD, PhD, FAAN (University of California San Francisco, Weill Institute for Neurosciences) Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Evidera. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals/Cavion. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial . Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Genentech. The institution of Dr. Tanner has received research support from Gateway LLC. The institution of Dr. Tanner has received research support from Roche\Genentech. The institution of Dr. Tanner has received research support from Michael J Fox Foundation . The institution of Dr. Tanner has received research support from National Institute of Health . The institution of Dr. Tanner has received research support from Department of Defense. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Faculty, CME presentation with Medscape /WebND.